1. CPX-351 exhibits potent and direct ex vivo cytotoxicity against AML blasts with enhanced efficacy for cells harboring the FLT3-ITD mutation. (February 2017) Authors: Gordon, Max J.; Tardi, Paul; Loriaux, Marc M.; Spurgeon, Stephen E.; Traer, Elie; Kovacsovics, Tibor; Mayer, Lawrence D.; Tyner, Jeffrey W. Journal: Leukemia research Issue: Volume 53(2017:Feb.) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗